Study of tumor markers in terms of their importance in the grade and stage of stomach cancer.
- Conditions
- Health Condition 1: C169- Malignant neoplasm of stomach, unspecified
- Registration Number
- CTRI/2021/05/033905
- Lead Sponsor
- Chittaranjan National Cancer Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 63
1. Patients who will be operated for gastric neoplasm and will be diagnosed with malignant
gastric epithelial neoplasms histopathologically.
2. Those who will give informed consent for taking part in the study.
1. After histopathological diagnosis all benign gastric neoplasms will be excluded.
2. After histopathological diagnosis gastric neoplasms other than malignant gastric epithelial
neoplasms will be excluded.
3. Cases where Neoadjuvant chemotherapy have been administered.
4. Those who are not willing to take part in the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method